Published in
American Society of Hematology, Blood Advances, 9(4), p. 1859-1866, 2020
DOI: 10.1182/bloodadvances.2019001325
Links
Tools
Mutational dynamics and immune evasion in diffuse large B-cell lymphoma explored in a relapse-enriched patient series
Journal article published in 2020 by
Jillian F. Wise 
,
Sigve Nakken ,
Chloé B. Steen ,
Daniel Vodák ,
Gunhild Trøen,
Bjarne Johannessen,
Ole Christian Lingjærde,
Vera Hilden,
Yngvild Nuvin Blaker,
Baoyan Bai,
Lars Birger Aasheim,
Annika Pasanen,
Susanne Lorenz ,
Anita Sveen,
Ragnhild A. Lothe
and other authors.
,
Sigve Nakken ,
Chloé B. Steen ,
Daniel Vodák ,
Gunhild Trøen,
Bjarne Johannessen,
Ole Christian Lingjærde,
Vera Hilden,
Yngvild Nuvin Blaker,
Baoyan Bai,
Lars Birger Aasheim,
Annika Pasanen,
Susanne Lorenz ,
Anita Sveen,
Ragnhild A. Lothe
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Postprint:
archiving forbidden
Data provided by 
Abstract
Key Points Diagnostic and relapse diffuse large B-cell lymphoma (DLBCL) biopsies reveal increased mutational burden/loss of heterozygosity in HLA-A. Serially sampled tumor biopsies provide insight into therapeutic targets and evolutionary divergence in relapsed/refractory DLBCL.